As of 2026-04-05, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -8.58 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.49 USD, the upside of Solid Biosciences Inc is -214.60%.
Based on its market price of 7.49 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 214.60%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -8.58 - -8.58 | -8.58 | -214.60% |
| P/E | (32.45) - (36.84) | (35.36) | -572.2% |
| DDM - Stable | (9.60) - (25.57) | (17.58) | -334.8% |
| DDM - Multi | (0.10) - (0.21) | (0.14) | -101.8% |
| Market Cap (mil) | 760.57 |
| Beta | 1.85 |
| Outstanding shares (mil) | 101.54 |
| Enterprise Value (mil) | 700.66 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.28% |
| Cost of Debt | 5.00% |
| WACC | 8.48% |